ASK REDCHAT ANYTHING ABOUT TSCAN THERAPEUTICS INC.
TScan Therapeutics Inc. (NASDAQ: TCRX)
Listen to this Section
$0.95
-0.0280
(
-2.86% )
291.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| TSC-100 & TSC-101DetailsCancer, Hematologic malignancies |
Phase 1 |
| TSC-203-A0201, TSC-200-A0201, TSC-204-A0201, TSC-204-C0702,TSC-201-B0702, TSC-204-A0101DetailsCancer, Solid tumor/s, Human papillomavirus |
Phase 1 |
Market Data
|
| Open |
$0.95 |
| Previous Close |
$0.98 |
| Volume |
291.2K |
| Market Cap |
$64.04M |
| Day Range |
$0.94 - $1.04 |
| 52 Week Range |
$0.88 - $2.57 |
| Shares Outstanding |
65.35M |
| Change % |
-2.86% |
| Net Change |
▼ -0.0280 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
5,858,839.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-05-21 |
Buy |
1388794.00 |
Lynx1 Capital Management LP |
| 2024-12-16 |
Buy |
31800.00 |
Lynx1 Capital Management LP |
| 2024-11-19 |
Buy |
947.00 |
Lynx1 Capital Management LP |
| 2024-09-24 |
Buy |
5000.00 |
Klencke Barbara |
| 2024-08-27 |
Buy |
5000.00 |
Klencke Barbara |
| 2024-06-14 |
Sale |
-47500.00 |
Woods Keith |
| 2024-06-14 |
Sale |
-47500.00 |
Dorton Katina |
| 2024-06-14 |
Sale |
-47500.00 |
BAKER BROS. ADVISORS LP |
| 2024-06-14 |
Sale |
-47500.00 |
Nicholson Garry A |
| 2024-06-14 |
Sale |
-47500.00 |
Gruia Gabriela |